Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Arrayit Corporation
  6. News
  7. Summary
    ARYC   US04269N1072

ARRAYIT CORPORATION

(ARYC)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration

09/24/2018 | 05:30am EST

Arrayit Corporation reported the shipment of clinical instrumentation and quantification software to the United States Food and Drug Administration (FDA). Arrayit uses the same instrumentation and software to test for allergy and food intolerance as well as pipeline indications for ovarian cancer and Parkinson’s Disease (PD). Testing is performed in the company’s Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the California Department of Public Health (CDPH) and the Center for Medicare and Medicaid Services (CMS). Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the FDA regarding approval of a major product line, reported the sale of clinical instrumentation to the FDA, signed allergy testing contracts with a consortium of 178 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers and was approved for direct Medicare billing by CMS. The clinical instrumentation and software shipped to the FDA, which regulates consumer products exceeding $1,000,000,000,000 ($1 trillion) in annual revenues, allows hands-on use by FDA scientists.


ę S&P Capital IQ 2018
All news about ARRAYIT CORPORATION
2020COVID-19 : Weekly Oversight And Enforcement Report—Week Of October 1, 2020
AQ
2020ARRAYIT : SEC Charges Top Executive of California Microcap Company for Misleading Claims C..
AQ
2020ARRAYIT : DOJ Announces Criminal Charges Against Lab Executive Accused Of Fraudulently Pro..
AQ
2020ARRAYIT : California tech CEO charged in coronavirus test fraud case
AQ
2019Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Tes..
GL
2019Arrayit Corporation Receives Approval as New Medicare Part B Healthcare Provider for Al..
CI
2019Arrayit Corporation Announces Global Expansion of Finger Stick Health and Wellness Test..
GL
2019Arrayit Corporation Announces Global Expansion of Finger Stick Health and Wellness Test..
CI
2019Arrayit Corporation Announces Allergy Testing Services Network Expansion to Multiple Cl..
GL
2019Arrayit Corporation Announces Allergy Testing Services Network Expansion to Multiple Cl..
CI
More news
Chart ARRAYIT CORPORATION
Duration : Period :
Arrayit Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Rene A. Schena Chairman & Chief Executive Officer
Mark Schena President, Secretary & Director
Todd J. Martinsky Director, Chief Technology Officer & EVP
Sector and Competitors
1st jan.Capi. (M$)
ARRAYIT CORPORATION-99.86%0
SARTORIUS AG37.97%39 650
BIOTAGE AB (PUBL)88.49%1 794
REVENIO GROUP OYJ6.26%1 601
VAREX IMAGING CORPORATION69.48%1 131
CELLAVISION AB (PUBL)4.82%827